Literature DB >> 10936787

The distribution of extracellular matrix proteins and CD44S expression in human astrocytomas.

B Oz1, F A Karayel, N L Gazio, F Ozlen, K Balci.   

Abstract

Aims of the study were: 1. to establish the prevalence of CD44 protein expression in human astrocytomas; 2. to compare the distribution of the extracellular matrix in these tumors; 3. to investigate the relation between CD 44, the extracellular matrix proteins and the histological grade of the tumor. CD44, Type IV Collagen (Col IV), Laminin (LN), Fibronectin (FN), and Tenascin (TN) expression were detected by immunohistochemistry in formalin fixed paraffin embedded tissue samples of 52 astrocytic tumors: 35 glioblastomas (GB), 7 Anaplastic astrocytomas (AA) and 10 astrocytomas (A). The localization of Col IV was observed in the basement membrane of the vessel walls in most of the astrocytomas (88.4%) with a similar pattern obtained with LN staining. 7 of 10 A (70%), 2 of 7 AA (28%) and 9 of 35 GB (25.7%) showed LN positivity. There was a negative correlation between LN expression and tumor grade (p=0.03). FN was either localized in the basement membrane or showed thick multi-layered immunoreactivity of the vessel walls. FN expression was seen in 6 A (60%), 4 AA (57%) and all of 35 GB (100%). The FN distribution was not uniform and its staining intensity showed decrease in GB. 3A (30%), 3 AA (42%), 27 GB (77.1%) showed TN expression in the vessel walls and in some tumor cells of 19 GBs. TN expression was positively correlated with the degree of vascular endothelial proliferation in GB (p<0.05). The expression of CD44s wasseen as plasma membrane positivity of glioma cells in 5 of 10A (50%), 3 of 7AA (42.3%) and 29 of 35 GB (82.8%). The intensity of immunoreaction was quite strong especially near the vessels. There was a good correlation between TN and CD44s expression in human astrocytic tumors (p=0.005). No relationship was observed between GFAP, ECM proteins and CD44s expression. Both CD44s and TN expression showed increase with malignancy in astrocytomas. These findings indicated that the histological malignancy of the astrocytomas was correlated with expression of TN and CD44s. It was suggested that in astrocytomas there was a biological relationship only between CD44 and TN, but none with the other ECM proteins. TN may play a role in angiogenesis in human astrocytic tumors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10936787     DOI: 10.1007/bf03032361

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  32 in total

1.  Loss of CD44 variant 6 expression differentiates small cell carcinoma of urinary bladder from urothelial (transitional cell) carcinoma.

Authors:  K A Iczkowski; J H Shanks; D G Bostwick
Journal:  Histopathology       Date:  1998-04       Impact factor: 5.087

2.  Differential distribution of tenascin in the normal, hyperplastic, and neoplastic breast.

Authors:  A A Howeedy; I Virtanen; L Laitinen; N S Gould; G K Koukoulis; V E Gould
Journal:  Lab Invest       Date:  1990-12       Impact factor: 5.662

3.  Expression of tenascin in human gliomas: its relation to histological malignancy, tumor dedifferentiation and angiogenesis.

Authors:  M Higuchi; T Ohnishi; N Arita; S Hiraga; T Hayakawa
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

4.  Determinants of human astrocytoma migration.

Authors:  A Giese; M D Rief; M A Loo; M E Berens
Journal:  Cancer Res       Date:  1994-07-15       Impact factor: 12.701

5.  Role of CD44 in the invasiveness of glioblastoma multiforme and the noninvasiveness of meningioma: an immunohistochemistry study.

Authors:  A Ariza; D López; J L Mate; M Isamat; E Musulén; M Pujol; A Ley; J J Navas-Palacios
Journal:  Hum Pathol       Date:  1995-10       Impact factor: 3.466

6.  Tenascin expression in human glioma cell lines and normal tissues.

Authors:  J B Ventimiglia; C J Wikstrand; L E Ostrowski; M A Bourdon; V A Lightner; D D Bigner
Journal:  J Neuroimmunol       Date:  1992-01       Impact factor: 3.478

7.  Expression of tenascin in tumors of the esophagus, small intestine and colorectum. An immunohistochemical study.

Authors:  R Broll; S Meyer; M Neuber; H P Bruch
Journal:  Gen Diagn Pathol       Date:  1995-10

8.  Localization of the CD44 glycoprotein to fibrous astrocytes in normal white matter and to reactive astrocytes in active lesions in multiple sclerosis.

Authors:  N Girgrah; M Letarte; L E Becker; T F Cruz; E Theriault; M A Moscarello
Journal:  J Neuropathol Exp Neurol       Date:  1991-11       Impact factor: 3.685

9.  Focal brain injury and upregulation of a developmentally regulated extracellular matrix protein.

Authors:  J A Brodkey; E D Laywell; T F O'Brien; A Faissner; K Stefansson; H U Dörries; M Schachner; D A Steindler
Journal:  J Neurosurg       Date:  1995-01       Impact factor: 5.115

10.  Induction of tenascin in healing wounds.

Authors:  E J Mackie; W Halfter; D Liverani
Journal:  J Cell Biol       Date:  1988-12       Impact factor: 10.539

View more
  5 in total

Review 1.  Biology of angiogenesis and invasion in glioma.

Authors:  Matthew C Tate; Manish K Aghi
Journal:  Neurotherapeutics       Date:  2009-07       Impact factor: 7.620

2.  Assessment of tumor cell invasion factors in gliomatosis cerebri.

Authors:  Christian Mawrin; Thomas Schneider; Raimund Firsching; Falk R Wiedemann; Knut Dietzmann; Antje Bornemann; Bernd F M Romeike; Bernd Sellhaus; Andreas von Deimling
Journal:  J Neurooncol       Date:  2005-06       Impact factor: 4.130

3.  CD44-mediated adhesion to hyaluronic acid contributes to mechanosensing and invasive motility.

Authors:  Yushan Kim; Sanjay Kumar
Journal:  Mol Cancer Res       Date:  2014-06-24       Impact factor: 5.852

4.  Locoregional radioimmunotherapy in selected patients with malignant glioma: experiences, side effects and survival times.

Authors:  C Goetz; P Riva; G Poepperl; F J Gildehaus; A Hischa; K Tatsch; H J Reulen
Journal:  J Neurooncol       Date:  2003-05       Impact factor: 4.130

5.  Irradiation differentially affects substratum-dependent survival, adhesion, and invasion of glioblastoma cell lines.

Authors:  N Cordes; B Hansmeier; C Beinke; V Meineke; D van Beuningen
Journal:  Br J Cancer       Date:  2003-12-01       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.